ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,021,591 | +12.9% | 34,819 | +4.6% | 0.00% | – |
Q2 2023 | $1,791,193 | +35.4% | 33,275 | -0.1% | 0.00% | – |
Q1 2023 | $1,323,192 | +2.5% | 33,313 | +3.8% | 0.00% | – |
Q4 2022 | $1,291,383 | -55.0% | 32,100 | -64.0% | 0.00% | – |
Q3 2022 | $2,869,000 | +12.7% | 89,265 | +4.0% | 0.00% | – |
Q2 2022 | $2,545,000 | -10.6% | 85,799 | -15.3% | 0.00% | – |
Q1 2022 | $2,846,000 | -61.2% | 101,272 | -36.4% | 0.00% | – |
Q4 2021 | $7,336,000 | +437.0% | 159,200 | +282.3% | 0.00% | – |
Q3 2021 | $1,366,000 | +49.6% | 41,648 | +60.0% | 0.00% | – |
Q2 2021 | $913,000 | +20.9% | 26,037 | +24.6% | 0.00% | – |
Q1 2021 | $755,000 | -32.3% | 20,900 | -45.6% | 0.00% | – |
Q4 2020 | $1,116,000 | +0.2% | 38,400 | -2.7% | 0.00% | – |
Q3 2020 | $1,114,000 | -59.7% | 39,465 | -53.8% | 0.00% | – |
Q2 2020 | $2,763,000 | +9.6% | 85,449 | +38.1% | 0.00% | – |
Q1 2020 | $2,522,000 | -29.8% | 61,886 | +6.3% | 0.00% | -100.0% |
Q4 2019 | $3,592,000 | -59.0% | 58,239 | -51.6% | 0.00% | -66.7% |
Q3 2019 | $8,763,000 | -60.4% | 120,254 | -55.3% | 0.00% | 0.0% |
Q2 2019 | $22,114,000 | +477.8% | 269,002 | +395.8% | 0.00% | +50.0% |
Q1 2019 | $3,827,000 | +163.9% | 54,257 | +68.4% | 0.00% | – |
Q4 2018 | $1,450,000 | -21.6% | 32,213 | -1.5% | 0.00% | – |
Q3 2018 | $1,849,000 | -70.6% | 32,700 | -65.2% | 0.00% | -100.0% |
Q2 2018 | $6,286,000 | -36.2% | 94,100 | -44.4% | 0.00% | -50.0% |
Q1 2018 | $9,857,000 | +48.5% | 169,300 | +64.4% | 0.00% | +100.0% |
Q4 2017 | $6,638,000 | +48.1% | 103,000 | +20.7% | 0.00% | +100.0% |
Q3 2017 | $4,481,000 | +20.1% | 85,370 | +7.1% | 0.00% | 0.0% |
Q2 2017 | $3,731,000 | -49.9% | 79,739 | -47.0% | 0.00% | -75.0% |
Q1 2017 | $7,444,000 | -21.2% | 150,351 | -3.6% | 0.00% | -20.0% |
Q4 2016 | $9,450,000 | -37.8% | 155,885 | -32.0% | 0.01% | -28.6% |
Q3 2016 | $15,201,000 | +23.1% | 229,108 | +3.6% | 0.01% | 0.0% |
Q2 2016 | $12,348,000 | +5.2% | 221,219 | -36.6% | 0.01% | +16.7% |
Q1 2016 | $11,739,000 | -43.8% | 348,780 | -24.6% | 0.01% | -33.3% |
Q4 2015 | $20,881,000 | +173.7% | 462,729 | +139.6% | 0.01% | +200.0% |
Q3 2015 | $7,630,000 | -31.3% | 193,123 | +7.9% | 0.00% | -40.0% |
Q2 2015 | $11,107,000 | +200.4% | 179,000 | +202.9% | 0.01% | +150.0% |
Q1 2015 | $3,697,000 | +475.0% | 59,101 | +418.9% | 0.00% | – |
Q4 2014 | $643,000 | +2.4% | 11,390 | -37.6% | 0.00% | – |
Q2 2014 | $628,000 | -17.7% | 18,244 | -25.0% | 0.00% | – |
Q1 2014 | $763,000 | -90.2% | 24,326 | -93.7% | 0.00% | -100.0% |
Q4 2013 | $7,783,000 | +106.2% | 387,600 | +0.3% | 0.00% | +50.0% |
Q3 2013 | $3,774,000 | – | 386,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |